search
Back to results

FRAME, External Support for Lower Limb Autologous Grafts

Primary Purpose

Peripheral Arterial Disease, Peripheral Artery Disease

Status
Suspended
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
FRAME
Sponsored by
Vascular Graft Solutions Ltd.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Peripheral Arterial Disease focused on measuring Saphenous vein graft, PAD, Peripheral bypass surgery, external support

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patient scheduled for infrainguinal peripheral artery bypass surgery with single segment autogenous saphenous vein.
  2. Rutherford classification 3-6
  3. Adequate revascularization target defined as an infrainguinal arterial segment distal to the area of stenosis/occlusion which can support a distal anastomosis of a surgical bypass.
  4. Patient is able and willing to give their informed written consent.
  5. Patient is able and willing to comply with study follow up requirements.
  6. Patient is ≥ 18 years of age

Exclusion Criteria:

  1. Patients indicated for endovascular treatment
  2. Prior surgical bypass procedure in ipsilateral lower limb.
  3. Active ulcer/infection/gangrene at the intended distal anastomosis site.
  4. Severe vein varicosity
  5. Saphenous vein with external pressurized diameter of less than 3.5 mm or more than 8 mm.
  6. Spliced vein technique
  7. In-situ vein technique
  8. Pedal/plantar distal anastomosis
  9. Planned above ankle amputation on ipsilateral limb within 4 weeks of index procedure.
  10. Patients with history of hypercoagulable conditions.
  11. Patients with significant stenoses distal to the planned anastomotic site and any other known conditions that could adversely affect graft patency.
  12. Concomitant life-threatening disease likely to limit life expectancy to less than 2 years.
  13. Contraindication to recommended study medications
  14. Participating in any other investigational study for either drug or device which can influence collection of valid data under this study.

Sites / Locations

  • Lutheran Hospital of Indiana
  • University of Maryland Baltimore
  • Mount Sinai Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

FRAME

Arm Description

Vein graft to be treated with FRAME

Outcomes

Primary Outcome Measures

Primary patency
Freedom of vein graft from occlusion and clinically driven target lesion revascularization as measured by Doppler Ultrasound

Secondary Outcome Measures

Full Information

First Posted
June 27, 2019
Last Updated
April 24, 2023
Sponsor
Vascular Graft Solutions Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT04003480
Brief Title
FRAME, External Support for Lower Limb Autologous Grafts
Official Title
Prospective, Multicenter Study Evaluating the Performance and Safety of FRAME, External Support for Lower Limb Autologous Grafts.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Suspended
Why Stopped
no patients have been enrolled. Study suspended due to change of sponsor priorities during COVID
Study Start Date
December 31, 2026 (Anticipated)
Primary Completion Date
December 2028 (Anticipated)
Study Completion Date
December 2029 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vascular Graft Solutions Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
30 patients will be enrolled in a prospective, multi-center, one-arm study, enrolling patients with claudication and chronic limb ischemia scheduled for lower limb venous bypass grafting on clinical grounds with single segment autologous saphenous vein. Subjects will be followed for 5 years, with follow up visits at 1, 3, 6, 12 months, 2, 3, 4, 5, years post operation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Arterial Disease, Peripheral Artery Disease
Keywords
Saphenous vein graft, PAD, Peripheral bypass surgery, external support

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
FRAME
Arm Type
Experimental
Arm Description
Vein graft to be treated with FRAME
Intervention Type
Device
Intervention Name(s)
FRAME
Intervention Description
External support for vein grafts in peripheral bypass surgery
Primary Outcome Measure Information:
Title
Primary patency
Description
Freedom of vein graft from occlusion and clinically driven target lesion revascularization as measured by Doppler Ultrasound
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patient scheduled for infrainguinal peripheral artery bypass surgery with single segment autogenous saphenous vein. Rutherford classification 3-6 Adequate revascularization target defined as an infrainguinal arterial segment distal to the area of stenosis/occlusion which can support a distal anastomosis of a surgical bypass. Patient is able and willing to give their informed written consent. Patient is able and willing to comply with study follow up requirements. Patient is ≥ 18 years of age Exclusion Criteria: Patients indicated for endovascular treatment Prior surgical bypass procedure in ipsilateral lower limb. Active ulcer/infection/gangrene at the intended distal anastomosis site. Severe vein varicosity Saphenous vein with external pressurized diameter of less than 3.5 mm or more than 8 mm. Spliced vein technique In-situ vein technique Pedal/plantar distal anastomosis Planned above ankle amputation on ipsilateral limb within 4 weeks of index procedure. Patients with history of hypercoagulable conditions. Patients with significant stenoses distal to the planned anastomotic site and any other known conditions that could adversely affect graft patency. Concomitant life-threatening disease likely to limit life expectancy to less than 2 years. Contraindication to recommended study medications Participating in any other investigational study for either drug or device which can influence collection of valid data under this study.
Facility Information:
Facility Name
Lutheran Hospital of Indiana
City
Fort Wayne
State/Province
Indiana
ZIP/Postal Code
46804
Country
United States
Facility Name
University of Maryland Baltimore
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
Facility Name
Mount Sinai Medical Center
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

FRAME, External Support for Lower Limb Autologous Grafts

We'll reach out to this number within 24 hrs